REQUEST A DEMO
Total
USD $0.00
Search more companies

Denta Bp Pharm D.O.O. Beograd (Serbia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Denta Bp Pharm D.O.O. Beograd Profile Updated: October 13, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Denta Bp Pharm D.O.O. Beograd is an enterprise located in Serbia, with the main office in Belgrade. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on September 04, 1993. It currently has a total number of 19 (2020) employees. In its most recent financial highlights, the company reported a net sales revenue drop of 6.34% in 2022. Its’ total assets recorded a negative growth of 0.21%. The enterprise’s net profit margin decreased by 0.91% in 2022.

Headquarters
Juzni Bulevar 19
Belgrade; Belgrade; Postal Code: 11000

Contact Details: Purchase the Denta Bp Pharm D.O.O. Beograd report to view the information.

Website: http://www.dentapharm.co.rs

Basic Information
Total Employees:
Purchase the Denta Bp Pharm D.O.O. Beograd report to view the information.
Outstanding Shares:
Purchase the Denta Bp Pharm D.O.O. Beograd report to view the information.
Registered Capital:
Purchase the Denta Bp Pharm D.O.O. Beograd report to view the information.
Incorporation Date:
September 04, 1993
Key Executives
Purchase this report to view the information.
Representative
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Denta Bp Pharm D.O.O. Beograd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
-6.34%
Total operating revenue
-6.34%
Operating profit (EBIT)
-18.74%
EBITDA
-16.25%
Net Profit (Loss) for the Period
-13.75%
Total assets
-0.21%
Total equity
14.45%
Operating Profit Margin (ROS)
-1.94%
Net Profit Margin
-0.91%
Return on Equity (ROE)
-4.93%
Debt to Equity Ratio
-5.2%
Quick Ratio
0.1%
Cash Ratio
-0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?